PD-Rx Pharmaceuticals, Inc. (PDRX)

USD 2.76

(0.0%)

Total Debt Summary of PD-Rx Pharmaceuticals, Inc.

  • PD-Rx Pharmaceuticals, Inc.'s latest annual total debt in 2022 was - USD , down 0.0% from previous year.
  • PD-Rx Pharmaceuticals, Inc.'s latest quarterly total debt in 2022 FY was - USD , down 0.0% from previous quarter.
  • PD-Rx Pharmaceuticals, Inc. reported annual total debt of - USD in 2021, down 0.0% from previous year.
  • PD-Rx Pharmaceuticals, Inc. reported annual total debt of - USD in 2020, down -100.0% from previous year.
  • PD-Rx Pharmaceuticals, Inc. reported quarterly total debt of - USD for 2021 FY, down 0.0% from previous quarter.
  • PD-Rx Pharmaceuticals, Inc. reported quarterly total debt of - USD for 2020 FY, down -100.0% from previous quarter.

Annual Total Debt Chart of PD-Rx Pharmaceuticals, Inc. (2022 - 2012)

Historical Annual Total Debt of PD-Rx Pharmaceuticals, Inc. (2022 - 2012)

Year Total Debt Total Debt Growth
2022 - USD 0.0%
2021 - USD 0.0%
2020 - USD -100.0%
2019 933.7 Thousand USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%

Peer Total Debt Comparison of PD-Rx Pharmaceuticals, Inc.

Name Total Debt Total Debt Difference
China Medicine Corporation 9.5 Million USD 100.0%
DH Enchantment Inc. 412.64 Thousand USD 100.0%
Exlites Holdings International, Inc. - USD NaN%
Itonis, Inc. 910.44 Thousand USD 100.0%
One Step Vending Corp. 252.26 Thousand USD 100.0%
MediPal Holdings Corporation 9.61 Million USD 100.0%
Pharmagen, Inc. 4588.24 USD 100.0%
Suzuken Co., Ltd. 11.91 Million USD 100.0%